Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs

Fig. 2

a Denaturing high-performance liquid chromotography (DHPLC) chromatograms: the peak profile of the case presented herein; the peak with a retention time of 1.53 min. (black arrow) indicates the presence of a heteroduplex caused by the presence of the mutation (c.1529C > T). the x-axis indicates DHPLC elution time in minutes and the y-axis the DNA concentration as measured by optical density at 260 nm in arbitrary units. A: b) Sanger sequencing chromatogram from the reverse primer of the renal sample and c) of the cutaneous samples, both indicating the presence of the primary (c.1523A > T; empty arrow) and secondary (c.1529C > T; plain arrowhead) mutations. The different heights of the peaks are evident. Likewise, the same pattern of mutations indicates the clonal origin of the primary lesion and distant metastasis

Back to article page